Cabinets to Bands... The template for this build can be found on my website: <a href=" → Yost clamps: <a href=" Social links: ...

In the wake of AI, unprecedented demand for data and computing power is outstripping capabilities. This will drive the ...

The Office star joins forces with Publicis to encourage employees to take time for cancer screenings. Publicis has tapped actor and breast cancer advocate Jenna Fischer to join the Working with Cancer ...

Through policy framework shifts, appeals to the court for rare disease funds, and starting a centre in Bengaluru, Prasanna ...

It then uses a different ML model to predict mutations and guide evolution of the identified template to improve affinity ... pharma companies - AstraZeneca, Merck, Pfizer, and Teva – along ...

Many people put them off and don't take advantage of employee benefits related to testing, according to Publicis Groupe's ...

Shares of global pharmaceutical company Merck (NYSE:MRK) fell 11% in the morning session after the company reported mixed fourth-quarter earnings. Its full-year revenue and EPS guidance missed by ...

Merck’s Q4 sales rose 7% YoY to $15.62B, slightly beating the $15.49B consensus. Adjusted EPS jumped to $1.72, topping estimates of $1.62. Keytruda sales grew 19% YoY to $7.84B, while Gardasil ...

For the recently completed fourth quarter, Merck booked an adjusted profit of $1.72 per share on $15.6 billion in revenue. Sales of top-selling cancer treatment Keytruda climbed 19% to $7.84 billion.

On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...

Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.

Merck MRK-9.07%decrease; red down pointing triangle shares tumbled more than 11% Tuesday morning after the drugmaker gave 2025 revenue guidance that fell short of analyst expectations and said it ...